Amiloride reduces portal hypertension in rat liver cirrhosis

Episode von Medizin - Open Access LMU - Teil 17/22 von Ludwig-Maximilians-Universität München · 1. Januar 2010

Objective This study aimed to investigate the effect of amiloride on portal hypertension. Amiloride is known to inhibit Na(+)/H(+) exchangers on activated hepatic stellate cells. Methods Liver cirrhosis in rats was induced by bile duct ligation (BDL) or thioacetamide (TAA) administration. The effects of zymosan for Kupffer cell (KC) activation or a thromboxane (TX) analogue (U46619) were tested in isolated perfused livers of cirrhotic rats and in vivo. Downstream mechanisms were investigated using Rho kinase inhibitor (Y-27632) or amiloride. Acute and chronic effects of amiloride and canrenoate on portal pressure were compared in perfused livers and in vivo. TXB(2) efflux was measured by ELISA. The phosphorylation state of moesin (p-moesin) as an indicator of Rho kinase activity and expression of the thromboxane synthase were assessed by western blot analyses. The activity of hepatic stellate cells was analysed by western blot and staining for alpha-smooth muscle actin (alpha-SMA). Results In BDL rats, KC activation via zymosan increased portal pressure. This was attenuated by the Rho kinase inhibitor Y-27632. Increased thromboxane efflux following zymosan infusion remained unaltered by Y-27632. The infusion of amiloride attenuated zymosan- and U46619-induced increases in portal perfusion pressure. In vivo, direct administration of amiloride, but not of canrenoate, lowered portal pressure. In TAA and BDL rats, treatment with amiloride for 3 days reduced basal portal pressure and KC-induced increases in portal pressure whereas canrenoate had no effect. In livers of amiloride-treated animals, the phosphorylation state of moesin and the number of alpha-SMA positive cells were reduced. Conclusions Amiloride lowers portal pressure in rat liver cirrhosis by inhibition of intrahepatic vasocontraction. Therefore, patients with cirrhosis and portal hypertension may benefit from amiloride therapy.

Weitere Episoden von „Medizin - Open Access LMU - Teil 17/22“

• 200 years Organon of Medicine - A comparative Review of its six editions (1810-1842) 1. Januar 2010
• A powerful transgenic tool for fate mapping and functional analysis of newly generated neurons 1. Januar 2010
• Air temperature and inflammatory and coagulation responses in men with coronary or pulmonary disease during the winter season 1. Januar 2010
• Ambient particulate pollution and the world-wide prevalence of asthma, rhinoconjunctivitis and eczema in children: Phase One of the International Study of Asthma and Allergies in Childhood (ISAAC) 1. Januar 2010
• Association between exposure to radiofrequency electromagnetic fields assessed by dosimetry and acute symptoms in children and adolescents: a population based cross-sectional study 1. Januar 2010
• Bone Morphogenetic Protein (BMP)-7 expression is decreased in human hypertensive nephrosclerosis 1. Januar 2010
• Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome 1. Januar 2010
• Deqi sensations without cutaneous sensory input: results of an RCT 1. Januar 2010
• Diagnostic indices for vertiginous diseases 1. Januar 2010
• How large are the nonspecific effects of acupuncture? A meta-analysis of randomized controlled trials 1. Januar 2010
• Impact of the indexed effective orifice area on mid-term cardiac-related mortality after aortic valve replacement 1. Januar 2010
• Increased expression of 5-hydroxytryptamine(2A/B) receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention 1. Januar 2010
• LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer 1. Januar 2010
• Minocycline is cytoprotective in human corneal endothelial cells and induces anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) and X-linked inhibitor of apoptosis (XIAP) 1. Januar 2010
• Molecular characterisation of congenital myasthenic syndromes in Southern Brazil 1. Januar 2010

Alle Episoden von Medizin - Open Access LMU - Teil 17/22 · Mehr Bildung-Podcasts